Q3312831 (Q3312831): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: import item from Germany) |
(Changed label, description and/or aliases in en: Setting new description) |
||
| description / en | description / en | ||
Project in Germany | Project Q3312831 in Germany | ||
Revision as of 16:10, 24 October 2021
Project Q3312831 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3312831 in Germany |
Statements
516,561.12 Euro
0 references
1,067,495.6 Euro
0 references
48.39 percent
0 references
17 March 2020
0 references
31 March 2022
0 references
HWI pharma services GmbH
0 references
76761
0 references
Mit der innovativen Screening- und Technologie-Plattform lassen sich parenterale (sterile) Arzneimittel mit schwerlöslichen chemischen und biologischen Wirkstoffen mittels Nanotechnologie schneller, effizienter und kostengünstiger entwickeln und herstellen. (German)
0 references
Germersheim
0 references
Identifiers
DE_TEMPORARY_15618
0 references